Mitsue Miyazaki

779 total citations
27 papers, 588 citations indexed

About

Mitsue Miyazaki is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Mitsue Miyazaki has authored 27 papers receiving a total of 588 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Pharmacology. Recurrent topics in Mitsue Miyazaki's work include Neurological disorders and treatments (4 papers), Pharmacogenetics and Drug Metabolism (4 papers) and Drug Transport and Resistance Mechanisms (3 papers). Mitsue Miyazaki is often cited by papers focused on Neurological disorders and treatments (4 papers), Pharmacogenetics and Drug Metabolism (4 papers) and Drug Transport and Resistance Mechanisms (3 papers). Mitsue Miyazaki collaborates with scholars based in Japan, United States and Netherlands. Mitsue Miyazaki's co-authors include Toshinori Hirai, Koujirou Yamamoto, Y. Kawashima, M. Hirato, Katsunori Nakamura, F. Peter Guengerich, Sachiko Tsukamoto, Nicole J. de Voogd, Henki Rotinsulu and T. Shibazaki and has published in prestigious journals such as The Journal of Immunology, Journal of neurosurgery and Journal of Neurology Neurosurgery & Psychiatry.

In The Last Decade

Mitsue Miyazaki

27 papers receiving 565 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mitsue Miyazaki Japan 12 191 163 118 78 77 27 588
Daniel Sevlever United States 16 263 1.4× 389 2.4× 92 0.8× 59 0.8× 31 0.4× 31 1.1k
Julius Halaschek-Wiener Canada 14 85 0.4× 420 2.6× 21 0.2× 155 2.0× 60 0.8× 15 832
Constantina Fotinou United Kingdom 11 167 0.9× 362 2.2× 145 1.2× 51 0.7× 9 0.1× 17 654
G. Siebert Australia 14 91 0.5× 186 1.1× 66 0.6× 129 1.7× 45 0.6× 39 485
Brigitte Lacroix France 15 25 0.1× 309 1.9× 83 0.7× 149 1.9× 21 0.3× 24 930
Piruz Nahreini United States 16 94 0.5× 472 2.9× 54 0.5× 91 1.2× 14 0.2× 35 890
Rea Valaperta Italy 17 53 0.3× 611 3.7× 200 1.7× 40 0.5× 31 0.4× 30 839
Esther Priel Israel 15 31 0.2× 408 2.5× 38 0.3× 121 1.6× 10 0.1× 39 720
Jonathan Zuccolo Canada 11 54 0.3× 222 1.4× 27 0.2× 54 0.7× 21 0.3× 14 546

Countries citing papers authored by Mitsue Miyazaki

Since Specialization
Citations

This map shows the geographic impact of Mitsue Miyazaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitsue Miyazaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitsue Miyazaki more than expected).

Fields of papers citing papers by Mitsue Miyazaki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitsue Miyazaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitsue Miyazaki. The network helps show where Mitsue Miyazaki may publish in the future.

Co-authorship network of co-authors of Mitsue Miyazaki

This figure shows the co-authorship network connecting the top 25 collaborators of Mitsue Miyazaki. A scholar is included among the top collaborators of Mitsue Miyazaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mitsue Miyazaki. Mitsue Miyazaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yamaguchi, Yuki, Takeshi Akiyoshi, Go Kawamura, et al.. (2021). Comparison of the inhibitory effects of azole antifungals on cytochrome P450 3A4 genetic variants. Drug Metabolism and Pharmacokinetics. 38. 100384–100384. 14 indexed citations
2.
Sato, Tomohiko, Diana Vargas, Kaoru Uchida, et al.. (2020). EID1 suppresses lipid accumulation by inhibiting the expression of GPDH in 3T3‐L1 preadipocytes. Journal of Cellular Physiology. 235(10). 6725–6735. 4 indexed citations
3.
4.
Hashimoto, Michihiro, Farzana Bhuyan, Masateru Hiyoshi, et al.. (2016). Potential Role of the Formation of Tunneling Nanotubes in HIV-1 Spread in Macrophages. The Journal of Immunology. 196(4). 1832–1841. 88 indexed citations
5.
Hashimoto, Michihiro, Hesham Nasser, Farzana Bhuyan, et al.. (2015). Fibrocytes Differ from Macrophages but Can Be Infected with HIV-1. The Journal of Immunology. 195(9). 4341–4350. 11 indexed citations
6.
Akiyoshi, Takeshi, Marie Ito, Mitsue Miyazaki, et al.. (2013). Mechanism-based Inhibition Profiles of Erythromycin and Clarithromycin with Cytochrome P450 3A4 Genetic Variants. Drug Metabolism and Pharmacokinetics. 28(5). 411–415. 24 indexed citations
7.
Miyazaki, Mitsue, Matthew P. Kodrasov, Henki Rotinsulu, et al.. (2013). Spongiacidin C, a pyrrole alkaloid from the marine sponge Stylissa massa, functions as a USP7 inhibitor. Bioorganic & Medicinal Chemistry Letters. 23(13). 3884–3886. 66 indexed citations
8.
Miyazaki, Mitsue, Hikaru Kato, Tadashi Watanabe, et al.. (2012). Hyrtioreticulins A–E, indole alkaloids inhibiting the ubiquitin-activating enzyme, from the marine sponge Hyrtios reticulatus. Bioorganic & Medicinal Chemistry. 20(14). 4437–4442. 61 indexed citations
9.
Akiyoshi, Takeshi, Takashi Saito, Mitsue Miyazaki, et al.. (2011). Comparison of the Inhibitory Profiles of Itraconazole and Cimetidine in Cytochrome P450 3A4 Genetic Variants. Drug Metabolism and Disposition. 39(4). 724–728. 19 indexed citations
10.
Miyazaki, Mitsue, Katsunori Nakamura, Yukiyoshi Fujita, et al.. (2008). Defective Activity of Recombinant Cytochromes P450 3A4.2 and 3A4.16 in Oxidation of Midazolam, Nifedipine, and Testosterone. Drug Metabolism and Disposition. 36(11). 2287–2291. 50 indexed citations
11.
Miyazaki, Mitsue, et al.. (2006). Influence of Atropine on the Dose Requirements of Propofol in Humans. Drug Metabolism and Pharmacokinetics. 21(5). 384–388. 6 indexed citations
12.
Miyazaki, Mitsue, et al.. (2005). Sexual differentiation in sensitivity to male body odor1. International Journal of Cosmetic Science. 27(6). 333–341. 6 indexed citations
13.
Miyazaki, Mitsue & Shinji Takai. (1999). Antiatherosclerotic Effect of Alacepril, an Angiotensin-Converting Enzyme Inhibitor, in Monkeys Fed a High-Cholesterol Diet.. Hypertension Research. 22(1). 49–54. 13 indexed citations
14.
Tamura, M., et al.. (1990). Adjunctive treatment for recurrent childhood ependymoma of the IV ventricle: chemotherapy with CDDP and MCNU. Child s Nervous System. 6(4). 186–189. 10 indexed citations
15.
Nagaseki, Y., T. Shibazaki, Toshinori Hirai, et al.. (1985). [Long-term follow-up study of selective VIM-thalamotomy].. PubMed. 37(6). 545–54. 1 indexed citations
16.
Yasuma, Fumihiko, K Yasuura, Hiroaki Okamoto, et al.. (1984). [Clinical application of diaphragm pacing].. PubMed. 37(6). 455–60. 1 indexed citations
17.
Miyazaki, Mitsue, et al.. (1982). [The influence of induced hypotension with prostaglandin E1 on the humoral factors: comparison with other vasodilators].. PubMed. 31(10). 1102–7. 2 indexed citations
18.
Nakajima, Hideko Heidi, et al.. (1981). [Correlation between neural noise and anatomical structures along the electrode track in the stereotactic thalamotomy-autopsy case study (author's transl)].. PubMed. 33(2). 131–7. 1 indexed citations
19.
Ohye, C., et al.. (1977). Physiologically controlled selective thalamotomy for the treatment of abnormal movement by Leksell's open system. Acta Neurochirurgica. 37(1-2). 93–104. 17 indexed citations
20.
Miyazaki, Mitsue, et al.. (1970). Formation of a new yellow crystalline compound from vanillic acid by the action of crude enzyme of Polyporus versicolor.. Journal of the Japan Wood Research Society. 16(4). 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniel Sevlever Breakdown of academic impact, for papers by Julius Halaschek-Wiener Breakdown of academic impact, for papers by Constantina Fotinou Breakdown of academic impact, for papers by G. Siebert Breakdown of academic impact, for papers by Brigitte Lacroix Breakdown of academic impact, for papers by Piruz Nahreini Breakdown of academic impact, for papers by Rea Valaperta Breakdown of academic impact, for papers by Esther Priel Breakdown of academic impact, for papers by Jonathan Zuccolo
Rankless by CCL
2026